Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

RMJ. 2012; 37(3): 293-295

Frequency of hypopharyngeal carcinoma in patients presenting with dysphagia

Fazal I Wahid, Musarrat Hussain, Qaisar Khan, Adil Khan, Iftikhar Ahmad Khan.

Objective: To determine the frequency of hypo pharyngeal carcinoma in patients presenting with dysphagia.
Material and Methods: This descriptive study was conducted at the department of Ear, Nose, Throat, Head and Neck Surgery, Postgraduate Medical Institute Lady Reading Hospital Peshawar from Jan. 2005 to Dec. 2010. It included 75 cases of hypopharyngeal carcinoma presented with dysphagia. All the patients were thoroughly evaluated in terms of history, examination and investigation. Rigid/ flexible endoscopy was performed and biopsy specimens were examined by same histopathologist and data was analyzed using SPSS version 17. Results: Out of 75 patients 43 were male and 32 were female, with male: female ratio of 1.34: 1.The age of the patients ranged from 34-83 years with mean age of 57.26 + S.D 14.01years. Most of the patients presented in 6th and 7th decade followed by the 5th and 4th decade of life. The main clinical features of these patients were progressive dysphagia (92%) and hoarseness (37.33%). Rigid hypopharyngoscopy was the commonest procedure of diagnosis (70.66%). Squamous cell carcinoma was the commonest (97.33%) tumour in these patients. Pyriform fossa was the commonest site of carcinoma hypopharynx (44%).
Conclusion: We can conclude that squamous cell carcinoma is the commonest tumour of hypopharynx. Pyriform fossa is the commonest site of affection in hypopharyngeal carcinoma. Hypopharyngeal carcinoma should be suspected if a male patients aged between 40 to 60 years presented with dysphagia.

Key words: Hypopharynx, Squamous cell carcinoma, dysphagia.

Similar Articles

Improving cell transplantation by understanding and manipulating the phagocytic activity of peripheral glia.
Nazareth L, St John J, Ekberg J
Neural regeneration research. 2022; 17(2): 313-314

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

Ca2+-dependent protein acyltransferase DHHC21 controls activation of CD4+ T cells.
Bieerkehazhi S, Fan Y, West SJ, Tewari R, Ko J, Mills T, Boehning D, Akimzhanov AM
Journal of cell science. 2022; 135(5):

Cell cycle exit and neuronal differentiation 1-engineered embryonic neural stem cells enhance neuronal differentiation and neurobehavioral recovery after experimental traumatic brain injury.
Wang R, Yang DX, Liu YL, Ding J, Guo Y, Ding WH, Tian HL, Yuan F
Neural regeneration research. 2022; 17(1): 130-136

Functionality of a bicistronic construction containing and genes encoding β-hexosaminidase A for cell-mediated therapy of GM2 gangliosidoses.
Shaimardanova AA, Chulpanova DS, Solovyeva VV, Aimaletdinov AM, Rizvanov AA
Neural regeneration research. 2022; 17(1): 122-129

Full-text options

Add your Article(s) to Indexes
• citeindex.org

Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.